penicillamine has been researched along with Hematologic Diseases in 13 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Hematologic Diseases: Disorders of the blood and blood forming tissues.
Excerpt | Relevance | Reference |
---|---|---|
"In the present study, the side effects of d-Penicillamine therapy in 54 patients with rheumatoid arthritis are analyzed." | 8.77 | [Side effects of d-penicillamine in the treatment of rheumatoid arthritis]. ( Bianchini, D; Cataldo, R; Damiani, D; Florean, M; Mazzanti, G; Mesesnel, E; Paladini, G, 1986) |
"The use of penicillamine in rheumatoid arthritis (RA) is limited by the incidence of adverse effects, some of which are potentially hazardous." | 8.76 | Penicillamine in rheumatoid arthritis: adverse effects. ( Hill, HF, 1979) |
"Adverse effects to D-penicillamine were studied prospectively over 3 years in 259 patients with rheumatoid arthritis." | 7.66 | Adverse effects of D-penicillamine in rheumatoid arthritis. ( Atkins, CJ; Offer, RC; Patterson, AC; Robinson, HS; Stein, HB; Teufel, A, 1980) |
"A retrospective study of penicillamine toxicity in 156 patients yielded a high incidence of toxic reaction (62%), necessitating discontinuation of the drug therapy in 36% of the patients." | 5.26 | Toxicity of penicillamine. A serious limitation to therapy in rheumatoid arthritis. ( Bernhard, GC; Goldman, AL; Halverson, PB; Kozin, F, 1978) |
"In the present study, the side effects of d-Penicillamine therapy in 54 patients with rheumatoid arthritis are analyzed." | 4.77 | [Side effects of d-penicillamine in the treatment of rheumatoid arthritis]. ( Bianchini, D; Cataldo, R; Damiani, D; Florean, M; Mazzanti, G; Mesesnel, E; Paladini, G, 1986) |
"The use of penicillamine in rheumatoid arthritis (RA) is limited by the incidence of adverse effects, some of which are potentially hazardous." | 4.76 | Penicillamine in rheumatoid arthritis: adverse effects. ( Hill, HF, 1979) |
"Adverse effects to D-penicillamine were studied prospectively over 3 years in 259 patients with rheumatoid arthritis." | 3.66 | Adverse effects of D-penicillamine in rheumatoid arthritis. ( Atkins, CJ; Offer, RC; Patterson, AC; Robinson, HS; Stein, HB; Teufel, A, 1980) |
"Reports on a variety of therapies for systemic lupus erythematosus have been published over the past year." | 2.38 | Treatment of systemic lupus erythematosus. ( Miller, ML, 1991) |
"The majority of patients were being treated for rheumatoid arthritis." | 1.27 | European League against Rheumatism study of adverse reactions to D-penicillamine. ( Kay, A, 1986) |
"A retrospective study of penicillamine toxicity in 156 patients yielded a high incidence of toxic reaction (62%), necessitating discontinuation of the drug therapy in 36% of the patients." | 1.26 | Toxicity of penicillamine. A serious limitation to therapy in rheumatoid arthritis. ( Bernhard, GC; Goldman, AL; Halverson, PB; Kozin, F, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (92.31) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sánchez Rodríguez, A | 1 |
González Macías, J | 1 |
Díez Jarilla, JL | 1 |
Suquia Múgica, B | 1 |
de Portugal Alvarez, J | 1 |
Stein, HB | 1 |
Patterson, AC | 1 |
Offer, RC | 1 |
Atkins, CJ | 1 |
Teufel, A | 1 |
Robinson, HS | 1 |
Krel', AA | 1 |
Ivanova, TS | 1 |
Hill, HF | 1 |
Halverson, PB | 1 |
Kozin, F | 1 |
Bernhard, GC | 1 |
Goldman, AL | 1 |
Miller, ML | 1 |
Kay, A | 1 |
Howard-Lock, HE | 1 |
Lock, CJ | 1 |
Mewa, A | 1 |
Kean, WF | 1 |
Mazzanti, G | 1 |
Paladini, G | 1 |
Damiani, D | 1 |
Bianchini, D | 1 |
Florean, M | 1 |
Mesesnel, E | 1 |
Cataldo, R | 1 |
Cuthbert, MF | 1 |
Albahary, C | 1 |
Witzgall, H | 1 |
Haley, TJ | 1 |
8 reviews available for penicillamine and Hematologic Diseases
Article | Year |
---|---|
[Wilson's disease. II].
Topics: Adolescent; Bone Diseases; Ceruloplasmin; Child; Copper; Eye Diseases; Female; Hematologic Diseases; | 1982 |
[Clinical use of d-penicillamine, complications and possibilities of their prevention].
Topics: Collagen Diseases; Dose-Response Relationship, Drug; Drug Eruptions; Drug Evaluation; Drug Hypersens | 1977 |
Penicillamine in rheumatoid arthritis: adverse effects.
Topics: Anemia, Aplastic; Anti-Glomerular Basement Membrane Disease; Arthritis, Rheumatoid; Bone Marrow; Dru | 1979 |
Treatment of systemic lupus erythematosus.
Topics: Hematologic Diseases; Humans; Immunosuppression Therapy; Lupus Erythematosus, Systemic; Lupus Nephri | 1991 |
D-penicillamine: chemistry and clinical use in rheumatic disease.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Drug Eruptions; Gold Sodium Thiomalate; Hematologic Dise | 1986 |
[Side effects of d-penicillamine in the treatment of rheumatoid arthritis].
Topics: Adult; Aged; Arthritis, Rheumatoid; Autoimmune Diseases; Drug Eruptions; Female; Hematologic Disease | 1986 |
Lead and hemopoiesis. The mechanism and consequences of the erythropathy of occupational lead poisoning.
Topics: Anemia; Bone Marrow Diseases; Cell Membrane; Cell Survival; Child; Edetic Acid; Erythrocytes; Erythr | 1972 |
Saturnism, pediatric and adult lead poisoning.
Topics: Adult; Central Nervous System Diseases; Chicago; Child; Child, Preschool; Edetic Acid; Environmental | 1971 |
5 other studies available for penicillamine and Hematologic Diseases
Article | Year |
---|---|
Adverse effects of D-penicillamine in rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Drug Administration Schedule; Gastrointestinal Disea | 1980 |
Toxicity of penicillamine. A serious limitation to therapy in rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; H | 1978 |
European League against Rheumatism study of adverse reactions to D-penicillamine.
Topics: Aged; Arthritis, Rheumatoid; Drug Eruptions; Europe; Female; Gastrointestinal Diseases; Hematologic | 1986 |
Adverse reactions to non-steroidal antirheumatic drugs.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Benzophenones; Chemical and Drug Induced Liv | 1974 |
[Gold therapy in chronic joint rheumatism].
Topics: Acute Kidney Injury; Arthritis, Rheumatoid; Dimercaprol; Drug Hypersensitivity; Gold; Hematologic Di | 1967 |